We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Crossref DOI link: https://doi.org/10.1186/s13054-016-1348-8
Published Online: 2016-06-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cotta, Menino Osbert
Roberts, Jason A.
Lipman, Jeffrey
Funding for this research was provided by:
National Health and Medical Research Council (APP1048652)